2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Sell
17
GPCR Quote, Financials, Valuation and Earnings
Last price:
$22.00
Seasonality move
:
47.59%
Day range:
$20.27 - $21.49
52-week range:
$19.39 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.40x
Volume:
786.7K
Avg. volume:
818.6K
1-year change:
-40.16%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$2.35
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.4M | $29.1M | $36.2M | $70.1M | $108.8M | |
| Selling, General & Admin | $3.5M | $8.6M | $16.4M | $32.7M | $49.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $15.9M | $37.7M | $52.6M | $102.8M | $158.2M | |
| Operating Income | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15.7M | -$37.8M | -$51.3M | -$89.4M | -$122.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $138K | $231K | $17K | $236K | $310K | |
| Net Income to Company | -$15.9M | -$38M | -$51.3M | -$89.6M | -$122.5M | |
| Minority Interest in Earnings | -- | -$2M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$16M | -$40M | -$51.3M | -$89.6M | -$122.5M | |
| Basic EPS (Cont. Ops) | -$0.64 | -$1.72 | -$1.38 | -$2.43 | -$2.34 | |
| Diluted EPS (Cont. Ops) | -$0.64 | -$1.72 | -$1.38 | -$2.43 | -$2.34 | |
| Weighted Average Basic Share | $25.1M | $25.5M | $38.2M | $36.7M | $52.6M | |
| Weighted Average Diluted Share | $25.1M | $25.5M | $38.2M | $36.7M | $52.6M | |
| EBITDA | -$15.9M | -$37.6M | -$52.3M | -$102.5M | -$157.2M | |
| EBIT | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Operating Income (Adjusted) | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $9.9M | $8.4M | $20M | $33.5M | |
| Selling, General & Admin | -- | $3.4M | $4.6M | $11M | $13.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $13.3M | $13M | $31M | $47.1M | |
| Operating Income | -- | -$13.3M | -$13M | -$31M | -$47.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$13.3M | -$12.1M | -$24.8M | -$36.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $81K | -$180K | -$312K | $136K | |
| Net Income to Company | -- | -- | -$11.9M | -$24.5M | -$36.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$11.7M | -$11.9M | -$24.5M | -$36.5M | |
| Basic EPS (Cont. Ops) | -- | -$0.61 | -$0.31 | -$0.48 | -$0.64 | |
| Diluted EPS (Cont. Ops) | -- | -$0.61 | -$0.31 | -$0.48 | -$0.64 | |
| Weighted Average Basic Share | -- | $25.5M | $38.2M | $46.3M | $57.3M | |
| Weighted Average Diluted Share | -- | $25.5M | $38.2M | $46.3M | $57.3M | |
| EBITDA | -- | -$13.2M | -$12.9M | -$30.9M | -$46.8M | |
| EBIT | -- | -$13.3M | -$13M | -$31M | -$47.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$13.3M | -$13M | -$31M | -$47.1M | |
| Operating Income (Adjusted) | -- | -$13.3M | -$13M | -$31M | -$47.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $36.2M | $70.1M | $108.8M | |
| Selling, General & Admin | -- | -- | $16.4M | $32.7M | $49.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | $52.6M | $102.8M | $158.2M | |
| Operating Income | -- | -- | -$52.6M | -$102.8M | -$158.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$51.3M | -$89.4M | -$122.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $17K | $236K | $310K | |
| Net Income to Company | -- | -- | -$51.3M | -$89.6M | -$122.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$51.3M | -$89.6M | -$122.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$1.92 | -$2.46 | -$2.35 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$1.92 | -$2.46 | -$2.35 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$52.3M | -$102.5M | -$157.2M | |
| EBIT | -- | -- | -$52.6M | -$102.8M | -$158.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$52.6M | -$102.8M | -$158.2M | |
| Operating Income (Adjusted) | -- | -- | -$52.6M | -$102.8M | -$158.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9.9M | $36.2M | $70.1M | $108.8M | -- | |
| Selling, General & Admin | $3.4M | $16.4M | $32.7M | $49.4M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $13.3M | $52.6M | $102.8M | $158.2M | -- | |
| Operating Income | -$13.3M | -$52.6M | -$102.8M | -$158.2M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$13.3M | -$51.3M | -$89.4M | -$122.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $81K | $17K | $236K | $310K | -- | |
| Net Income to Company | -- | -$51.3M | -$89.6M | -$122.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.7M | -$51.3M | -$89.6M | -$122.5M | -- | |
| Basic EPS (Cont. Ops) | -$0.61 | -$1.92 | -$2.46 | -$2.35 | -- | |
| Diluted EPS (Cont. Ops) | -$0.61 | -$1.92 | -$2.46 | -$2.35 | -- | |
| Weighted Average Basic Share | $25.5M | $114.7M | $146.8M | $210.5M | -- | |
| Weighted Average Diluted Share | $25.5M | $114.7M | $146.8M | $210.5M | -- | |
| EBITDA | -$13.2M | -$52.3M | -$102.5M | -$157.2M | -- | |
| EBIT | -$13.3M | -$52.6M | -$102.8M | -$158.2M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$13.3M | -$52.6M | -$102.8M | -$158.2M | -- | |
| Operating Income (Adjusted) | -$13.3M | -$52.6M | -$102.8M | -$158.2M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.4M | $105.3M | $26.1M | $129.8M | $169.5M | |
| Short Term Investments | $21.1M | $2M | $64.8M | $337.5M | $714M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $974K | $1.9M | $2.2M | $6.3M | $7.7M | |
| Total Current Assets | $38.4M | $109.3M | $93.1M | $473.6M | $891.2M | |
| Property Plant And Equipment | $277K | $1.8M | $1.3M | $8.4M | $7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $8K | $111K | $3.5M | $45K | $5.1M | |
| Total Assets | $38.7M | $111.2M | $97.8M | $482M | $903.3M | |
| Accounts Payable | $1.5M | $3.5M | $6M | $4.7M | $8M | |
| Accrued Expenses | $408K | $2.7M | $3M | $14.2M | $19M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $147K | $349K | $260K | $1.4M | $1.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3M | $8.7M | $13M | $24.7M | $36M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $61.2M | $175.9M | $213M | $29.1M | $38.5M | |
| Common Stock | $1K | $1K | $1K | $14K | $17K | |
| Other Common Equity Adj | -$1K | -- | -$110K | $521K | $914K | |
| Common Equity | -$22.5M | -$64.7M | -$115.1M | $453M | $864.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$22.5M | -$64.7M | -$115.1M | $453M | $864.8M | |
| Total Liabilities and Equity | $38.7M | $111.2M | $97.8M | $482M | $903.3M | |
| Cash and Short Terms | $37.4M | $107.3M | $90.8M | $467.3M | $883.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $105.3M | $26.1M | $129.8M | $169.5M | |
| Short Term Investments | -- | $2M | $64.8M | $337.5M | $714M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $1.9M | $2.2M | $6.3M | $7.7M | |
| Total Current Assets | -- | $109.3M | $93.1M | $473.6M | $891.2M | |
| Property Plant And Equipment | -- | $1.8M | $1.3M | $8.4M | $7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $111K | $3.5M | $45K | $5.1M | |
| Total Assets | -- | $111.2M | $97.8M | $482M | $903.3M | |
| Accounts Payable | -- | $3.5M | $6M | $4.7M | $8M | |
| Accrued Expenses | -- | $2.7M | $3M | $14.2M | $19M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $349K | $260K | $1.4M | $1.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $8.7M | $13M | $24.7M | $36M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $175.9M | $213M | $29.1M | $38.5M | |
| Common Stock | -- | $1K | $1K | $14K | $17K | |
| Other Common Equity Adj | -- | -- | -$110K | $521K | $914K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$64.7M | -$115.1M | $453M | $864.8M | |
| Total Liabilities and Equity | -- | $111.2M | $97.8M | $482M | $903.3M | |
| Cash and Short Terms | -- | $107.3M | $90.8M | $467.3M | $883.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.9M | -$38M | -$51.3M | -$89.6M | -$122.5M | |
| Depreciation & Amoritzation | -- | $72K | $277K | $295K | $992K | |
| Stock-Based Compensation | $570K | $1.5M | $2.5M | $8.2M | $18.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$14.3M | -$32.2M | -$46.1M | -$79.5M | -$116.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$21.1M | $17.9M | -$62.1M | -$268.3M | -$358.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$115K | -$2.5M | -$21.6M | -$1.8M | |
| Cash From Financing | $25.8M | $103.3M | $29M | $451.5M | $515.3M | |
| Beginning Cash (CF) | $25.9M | $16.4M | $105.3M | $26.1M | $129.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$9.6M | $89M | -$79.2M | $103.7M | $39.7M | |
| Ending Cash (CF) | $16.4M | $105.3M | $26.1M | $129.8M | $169.5M | |
| Levered Free Cash Flow | -$14.3M | -$33.4M | -$46.3M | -$81.7M | -$117.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$11.9M | -$24.5M | -$36.5M | |
| Depreciation & Amoritzation | -- | -- | $72K | $72K | $273K | |
| Stock-Based Compensation | -- | -- | $623K | $2.1M | $5.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$12M | -$21.7M | -$36.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $10.3M | -$180.7M | $33.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$316K | -$18.5M | -- | |
| Cash From Financing | -- | -- | -$316K | $281.6M | $615K | |
| Beginning Cash (CF) | -- | -- | $28.1M | $50.6M | $172.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$2M | $79.2M | -$2.6M | |
| Ending Cash (CF) | -- | -- | $26.1M | $129.8M | $169.5M | |
| Levered Free Cash Flow | -- | -- | -$12.1M | -$22.9M | -$36.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$51.3M | -$89.6M | -$122.5M | |
| Depreciation & Amoritzation | -- | -- | $277K | $295K | $992K | |
| Stock-Based Compensation | -- | -- | $2.5M | $8.2M | $18.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$46.1M | -$79.5M | -$116.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$62.1M | -$268.3M | -$358.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$2.5M | -$21.6M | -$1.8M | |
| Cash From Financing | -- | -- | $29M | $451.5M | $515.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$79.2M | $103.7M | $39.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$46.3M | -$81.7M | -$117.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$51.3M | -$89.6M | -$122.5M | -- | |
| Depreciation & Amoritzation | -- | $277K | $295K | $992K | -- | |
| Stock-Based Compensation | -- | $2.5M | $8.2M | $18.8M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$46.1M | -$79.5M | -$116.6M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$62.1M | -$268.3M | -$358.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$2.5M | -$21.6M | -$1.8M | -- | |
| Cash From Financing | -- | $29M | $451.5M | $515.3M | -- | |
| Beginning Cash (CF) | -- | $239.5M | $243.8M | $781.4M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$79.2M | $103.7M | $39.7M | -- | |
| Ending Cash (CF) | -- | $160.3M | $347.5M | $821.1M | -- | |
| Levered Free Cash Flow | -- | -$46.3M | -$81.7M | -$117.9M | -- | |
Get GPCR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GPCR
Sector
P/E ratio
--
24.13x
PEG ratio
--
0.00x
P/B ratio
1.40x
1.69x
Price / LTM sales
--
1.71x
Growth Metrics
GPCR
Sector
Revenue growth
--
6.54%
Earnings growth
--
6.3%
Revenue (5-year growth)
--
9.13%
Earnings forecast
-$0.17
-$0.20
Profitability
GPCR
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.96%
Return on assets
--
-12.4%
Return on equity
--
-17.27%
Earnings Date
Last Earnings Date
Feb
27
Next Earnings Date
May
9
Estimated Next Earnings Date
May
29
Balance Sheet
GPCR
Sector
Total cash
$883.5M
$44.5M
Short term investments
$714M
$39.2M
Total assets
$903.3M
$126.6M
Long term debt
--
$9.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Is Goldman Sachs Stock a Buy Sell or Hold?
When the Federal Reserve started hiking rates in 2022, banks’…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 1.02% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.08% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 6.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
